MOUNTAIN VIEW, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced a recently published independent, retrospective study in Ophthalmology and Therapy. The study demonstrates that retreatment of transscleral laser treatment using MicroPulse® technology (MicroPulse TLT) can safely and effectively furthe ...

青光眼及MIGS市场总体前景 - 青光眼是全球不可逆失明的主要原因 患者需要更多微创或侵入性更小的介入治疗方案以控制疾病 [1] - MIGS在改善患者临床结果方面已取得重大进展 除MIGS外还有其他令人兴奋的介入方法 [1] - 尽管今年存在医保覆盖政策变更带来的逆风 但预计该逆风将在第四季度减弱 [1] MIGS市场增长预期 - 患者就诊量持续增长 [2] - 预计MIGS市场将在2026年恢复增长 [2] - 公司在面临市场逆风的情况下 其商业团队表现获得认可 [2]